Finzati - Logo
DRUG logo

Bright Minds Biosciences Inc.

DRUG • Biotechnology
$65.16
▼ -2.86 (-4.20%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$822.51M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 36.1Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:10 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$65.16
Change-4.20%
Market Cap$822.51M
52W Range38.00 - 123.75
Beta0.09
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio36.10
Quick Ratio36.10
Target$182.50

Investment DNA

How strong this company looks for long-term investors

39
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 36.1Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-19
Low
$145.00
Mean
$182.50
Median
$182.50
High
$220.00

Company Overview

IPO: 3/22/2021
Industry: Biotechnology
P/B i: 7.08
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.00
Current Ratio: 36.10
Quick Ratio: 36.10
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Cormorant Asset Management, LP
Transaction: 04/28/2026
SELL
Change
-109,331
Price
$89.50
Filing
04/30/2026
Type
SELL
Cormorant Asset Management, LP
Transaction: 11/04/2024
BUY
Change
+184,331
Price
$21.70
Filing
11/06/2024
Type
BUY
Cormorant Asset Management, LP
Transaction: 10/16/2024
BUY
Change
+39,743
Price
$23.21
Filing
10/17/2024
Type
BUY